|
21 Jul 2019 |
Ascendis Pharma Announces Filing of Investigational New Drug (IND) Application for Initiation of a Global Phase 2 Trial for TransCon™ CNP in Children with Achondroplasia
|
|
21 Jul 2019 |
PMZ-1620, an Endothelin-B Agonist, enters Phase III Trial in Patients with Cerebral Ischemic Stroke
|
|
21 Jul 2019 |
Marker Therapeutics Reports Interim Results of its MultiTAA T Cell Therapy in Patients with Pancreatic Adenocarcinoma at AACR
|
|
21 Jul 2019 |
FDA Approves OTEZLA® (apremilast) for the Treatment of Oral Ulcers Associated with Behçet’s Disease
|
|
21 Jul 2019 |
Janssen Seeks EMA Approval for Novel Subcutaneous Formulation of DARZALEX® (daratumumab)
|
|
21 Jul 2019 |
Gilead Sciences Licenses Respiratory and Herpes Antiviral Research Programs From Novartis
|
|
19 Jul 2019 |
EMA Accepts Samsung Bioepis’ MAA for SB8 Bevacizumab Biosimilar Candidate
|
|
19 Jul 2019 |
Eisai Presented Data Showing Quantification of Tau Microtubule Binding Region at AAIC 2019
|
|
18 Jul 2019 |
MyoKardia Announces HCM Program Updates: Accelerates Timing for Mavacamten Topline Phase 3 Data; Re-acquires U.S. Royalty Rights to HCM Programs from Sanofi
|
|
18 Jul 2019 |
Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases
|
|
18 Jul 2019 |
Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors
|
|
18 Jul 2019 |
Transgene Receives MHRA Approval for a Clinical Trial of TG6002, a Next-generation Oncolytic Virus, Administered by Intrahepatic Artery Infusion in Patients with Colorectal Cancer with Liver Metastases
|
|
18 Jul 2019 |
MacroGenics Provides Update on Flotetuzumab Program in Acute Myeloid Leukemia
|
|
18 Jul 2019 |
Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics
|
|
18 Jul 2019 |
Bayer, Bristol-Myers Squibb and Ono Pharmaceutical Enter Into a Clinical Collaboration Agreement to Investigate Stivarga® (regorafenib) and Opdivo® (nivolumab) as Combination Therapy in Patients With Metastatic Colorectal Cancer
|
|
18 Jul 2019 |
Sernova's Phase I/II US Clinical Trial for Type-1 Diabetes Advances Following Positive Preliminary Safety and Efficacy Data
|
|
18 Jul 2019 |
Adaptimmune Starts the SURPASS Clinical Trial with its first Next-Generation SPEAR T-cells Targeting MAGE‑A4 to Enhance Antitumor Responses
|
|
18 Jul 2019 |
Zydus announces completion of enrollment in three Phase III trials of Saroglitazar Magnesium in NASH
|
|
18 Jul 2019 |
Eisai presents nonclinical research results of elenbecestat of without significant effects on synaptic function in brain by spinal densitiy evaluation at effective dose to decrease amyloid beta level in cerebrospinal fluid at AAIC 2019
|
|
17 Jul 2019 |
Seelos Therapeutics Announces Investigational New Drug Application Submission for SLS-005
|
